Healthcare · Medical Devices
Profusa, Inc.
PFSANASDAQ$0.32−$0.02 (−6.53%)Market closed
USD
USD
% of revenue
Statements
5 periods| Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | |||||
| Sales | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Gross Margin | — | — | — | — | — |
| Operating | |||||
| SG&A | 24.9M | 3.0M | 4.1M | 5.2M | 4.8M |
| R&D | 2.8M | 1.6M | 2.0M | 4.2M | 7.7M |
| Other Expenses | — | −100.0K | −45.0K | — | −742.0K |
| Operating Income | −27.7M | −4.5M | −6.1M | −9.4M | −11.7M |
| Operating Margin | — | — | — | — | — |
| EBITDA | −33.6M | −4.8M | −6.0M | −8.7M | −10.2M |
| EBITDA Margin | — | — | — | — | — |
| EBIT | −33.3M | −4.8M | −6.0M | −13.9M | −6.2M |
| Non-Operating | |||||
| Other Income | — | — | — | — | — |
| Other Expenses | 2.5M | 4.4M | 4.3M | 6.3M | 4.1M |
| Other Income/Expense | −3.0M | −306.0K | 72.0K | −4.5M | 5.5M |
| Net Income | |||||
| Income Before Tax | −35.8M | −9.2M | −10.3M | −20.2M | −10.3M |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — |
| Net Income | −35.8M | −9.2M | −10.3M | −20.2M | −10.3M |
| Net Margin | — | — | — | — | — |